Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest Bisphosphonates Stories

2014-03-20 16:27:05

New products from Mission ideal for nursing home environment. SAN ANTONIO, March 20, 2014 /PRNewswire/ -- Mission Pharmacal Company is introducing a portfolio of proven products into the long-term care environment. The company has always held steadfast to its dedication to provide the highest quality healthcare medications and treatments for a wide range of conditions and diseases. http://photos.prnewswire.com/prnvar/20140320/PH87885LOGO The long-term care (LTC) initiative capitalizes on...

2014-01-15 16:23:21

BINOSTO® offers a liquid alternative to the 74 percent of patients who want a treatment choice. SAN ANTONIO, Jan. 15, 2014 /PRNewswire/ -- Most osteoporosis patients want a choice in the medication they take, according to a recent online survey* sponsored by Mission Pharmacal Company. The survey, conducted by Inspire among the National Osteoporosis Foundation online support community, revealed that 74 percent of osteoporosis patients surveyed prefer to take medication that comes in...

2014-01-12 23:01:32

The Firm is representing plaintiffs in Fosamax lawsuits that allege use of the drug caused patients to sustain painful and debilitating femur fractures New York, NY (PRWEB) January 12, 2014 Thousands of Fosamax lawsuits (http://www.consumerinjurylawyers.com/fosamax/Fosamax-Femur-Fracture-Lawsuits.html) filed on behalf of women who sustained femur fractures, allegedly due to their use of the medication, continue to move forward in state and federal courts throughout the country,...

2013-12-10 23:02:10

The firm is actively filing Fosamax lawsuits on behalf of those who allegedly suffered femur fractures, necrosis of the jaw and other serious complications related to their use of the drug. (PRWEB) December 10, 2013 Drugmaker Merck announced on Dec. 9 that it has agreed to pay about $28 million to settle Fosamax lawsuits stemming from claims that the osteoporosis drug caused patients’ jaws to deteriorate, or even “die,” according to Reuters. The Rottenstein Law Group LLP notes that...

2013-11-11 23:00:44

ChinaMarketResearchReports.com adds Latest Report on “Research Report on China Osteoporosis Drug Market, 2013-2017” to its store. Dallas, TX (PRWEB) November 12, 2013 Osteoporosis is a systemic bone disease, a common disease among middle and old-aged people. It is characterized by low bone mineral density and deterioration of bone microarchitecture, which can lead to increased risks of fragility fracture. There are over 200 million osteoporosis patients around the world in the current...

2013-11-07 15:37:01

A recent prospective, randomized, placebo-controlled clinical trial reports that calcium and vitamin D supplementation improves bone density in a group of male veterans with epilepsy who were treated chronically with antiepileptic drugs (AEDs). The results published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), suggest that risedronate, a bisphosphonate, may help to prevent new vertebral fractures when taken with calcium and vitamin D supplementation. Many...

2013-10-26 23:01:03

The Firm is currently offering free and confidential Fosamax lawsuit evaluations to individuals who may have suffered atypical femur fractures after long-term use of the medication. New York, NY (PRWEB) October 26, 2013 More than 2,900 cases have now been filed in a consolidated Fosamax lawsuit (http://www.consumerinjurylawyers.com/fosamax/Fosamax-Femur-Fracture-Lawsuits.html) litigation established in New Jersey’s Atlantic County Superior Court, Bernstein Liebhard LLP reports....

2013-10-11 23:19:25

On October 3, a New York federal judge delayed the transfer of hundreds of Fosamax lawsuits in the Multidistrict Litigation to give the manufacturer and plaintiffs the opportunity to reach a settlement. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Fosamax side effects. San Diego, CA (PRWEB) October 11, 2013 AttorneyOne.com, a recognized...

2013-10-04 08:23:39

Prolia Open-Label Extension Trial Showed Continued Increases in Bone Mineral Density and Low Fracture Incidence for Up to Eight Years THOUSAND OAKS, Calif., Oct. 4, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will present data from several romosozumab and Prolia(®) (denosumab) studies at the American Society for Bone and Mineral Research (ASBMR) 2013 Annual Meeting in Baltimore from Oct. 4-7, 2013. Romosozumab data include results from the Phase 2 study that demonstrate...

2013-09-12 23:18:41

Transparency Market Research published new "Global Osteoporosis Drug Market- China Industry Analysis, Size, Share, Growth, Trends and Forecast, 2010 - 2015" market research report to its report store. Browse the report with TOC; visit http://www.transparencymarketresearch.com/osteoporosis-drug-market.html. Albany, New York (PRWEB) September 12, 2013 According to Transparency Market Research “Osteoporosis Drug Market- Global and China market analysis, size, trends and forecast...